NFKB1 and inflammatory bowel disease: Therefore, it was necessary to further study the effects of mesalazine on NF-κB activation-related factors (e.g., COX-2, IL-1, p-NF-κB /P65), to improve the understanding of the therapeutic process of mesalazine for IBD.